1,015
Participants
Start Date
November 8, 2023
Primary Completion Date
July 17, 2024
Study Completion Date
July 17, 2024
31 valent pneumococcal conjugate vaccine
0.5 ml dose of VAX-31 was administered into the deltoid muscle at Day 1
20 valent pneumococcal conjugate vaccine
0.5 ml dose of PCV20 was administered into the deltoid muscle at Day 1
Rochester Clinical Research, Rochester
DM Clinical Research - Philadelphia, Philadelphia
Charlottesville Medical Research, Charlottesville
Health Research of Hampton Roads, Newport News
Coastal Carolina Research, North Charleston
Velocity Clinical Research, Savannah, Savannah
Optimal Research, Melbourne
Research Centers of America, Hollywood
Precision Clinical Research, Sunrise
Health Awareness, Jupiter
AMR Mobile, Mobile
AMR Knoxville, Knoxville
Velocity Clinical Research, Cleveland, Cleveland
CTI Clinical Research Center, Cincinnati
DM Clinical Research - Detroit, Detroit
Healthcare Research Network II, LLC, Flossmoor
Johnson County Clin-Trials, Lenexa
Velocity Clinical Research Omaha, Omaha
Benchmark Research, Fort Worth
Benchmark Research, San Angelo
CenExel JBR Clinical Research, Salt Lake City
AMR Phoenix, Phoenix
WR-CRCN, Las Vegas
Cenexel AMRI, Toms River
Velocity Clinical Research, Warwick
Vaxcyte, Inc.
INDUSTRY